<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
        </div>
        <div class="card-body">
                <p>Activation of activator protein 1 (AP-1) and nuclear factor kappaB (NFkappaB)-dependent transcription is required for tumor promotion in cell culture models and transgenic mice. Dominant-negative c-Jun (TAM67) blocks AP-1 activation by dimerizing with Jun or Fos family proteins and blocks NFkappaB activation by interacting with NFkappaB p65. Two-stage [7,12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)] skin carcinogenesis experiments in a model relevant to human cancer risk, transgenic mice expressing human papillomavirus 16 E7 oncogene (K14-HPV16-E7), show E7-enhanced tumor promotion. A cross to K14-TAM67-expressing mice results in dramatic inhibition of tumor promoter-induced AP-1 luciferase reporter activation and papillomagenesis. Epithelial specific TAM67 expression inhibits tumorigenesis without affecting TPA- or E7-induced hyperproliferation of the skin. Thus, the mouse model enriches for TAM67 targets relevant to tumorigenesis rather than to general cell proliferation or hyperplasia, implicating a subset of AP-1- and/or NFkappaB-dependent genes. The aim of the present study was to identify target genes responsible for TAM67 inhibition of DMBA-TPA-induced tumorigenesis. Microarray expression analysis of epidermal tissues revealed small sets of genes in which expression is both up-regulated by tumor promoter and down-regulated by TAM67. Among these, cyclooxygenase-2 (Cox-2/Ptgs2) and osteopontin (Opn/Spp1) are known to be functionally significant in driving carcinogenesis. Results identify both Cox-2 and Opn as transcriptional targets of TAM67 with CRE, but not NFkappaB sites important in the Cox-2 promoter and an AP-1 site important in the Opn promoter.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M1848">M1848</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:10090">NCBITaxon:10090</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:2980">ncbigene:2980</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4688">ncbigene:4688</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3495">ncbigene:3495</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:389125">ncbigene:389125</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2920">ncbigene:2920</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:27177">ncbigene:27177</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8824">ncbigene:8824</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6696">ncbigene:6696</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:79026">ncbigene:79026</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:30001">ncbigene:30001</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:79886">ncbigene:79886</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5916">ncbigene:5916</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5329">ncbigene:5329</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2358">ncbigene:2358</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8717">ncbigene:8717</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3909">ncbigene:3909</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:810">ncbigene:810</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:241">ncbigene:241</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M1848&#39;, name=&#39;MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN&#39;), definition=&#39;Activation of activator protein 1 (AP-1) and nuclear factor kappaB (NFkappaB)-dependent transcription is required for tumor promotion in cell culture models and transgenic mice. Dominant-negative c-Jun (TAM67) blocks AP-1 activation by dimerizing with Jun or Fos family proteins and blocks NFkappaB activation by interacting with NFkappaB p65. Two-stage [7,12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)] skin carcinogenesis experiments in a model relevant to human cancer risk, transgenic mice expressing human papillomavirus 16 E7 oncogene (K14-HPV16-E7), show E7-enhanced tumor promotion. A cross to K14-TAM67-expressing mice results in dramatic inhibition of tumor promoter-induced AP-1 luciferase reporter activation and papillomagenesis. Epithelial specific TAM67 expression inhibits tumorigenesis without affecting TPA- or E7-induced hyperproliferation of the skin. Thus, the mouse model enriches for TAM67 targets relevant to tumorigenesis rather than to general cell proliferation or hyperplasia, implicating a subset of AP-1- and/or NFkappaB-dependent genes. The aim of the present study was to identify target genes responsible for TAM67 inhibition of DMBA-TPA-induced tumorigenesis. Microarray expression analysis of epidermal tissues revealed small sets of genes in which expression is both up-regulated by tumor promoter and down-regulated by TAM67. Among these, cyclooxygenase-2 (Cox-2/Ptgs2) and osteopontin (Opn/Spp1) are known to be functionally significant in driving carcinogenesis. Results identify both Cox-2 and Opn as transcriptional targets of TAM67 with CRE, but not NFkappaB sites important in the Cox-2 promoter and an AP-1 site important in the Opn promoter.&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;17363560&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;10090&#39;, name=&#39;Mus musculus&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2980&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4688&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3495&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;389125&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2920&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;27177&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8824&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6696&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;79026&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;30001&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;79886&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5916&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5329&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2358&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8717&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3909&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;810&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;241&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Jessica Robertson&#39;], &#39;exact_source&#39;: [&#39;Table 1AS-1CS&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>